No new cases of COVID-19 in Hidalgo County

Breaking NewsCommunity News
341

Translate to Spanish or other 102 languages!

Image for illustration purposes only

Mega Doctor News

- Advertisement -

Edinburg – There were no new cases of COVID-19 in Hidalgo County on Tuesday, the first day this has happened since a McAllen woman tested positive for the virus on March 21, Hidalgo County Judge Richard F. Cortez said. The number of positive cases remains at 353.

“This is great news, but we shouldn’t let our guard down,” Judge Cortez said. “We need to keep this up by continuing to practice the safety measures that we have been practicing, including staying at home, good hygiene and avoiding crowds.”

Hidalgo County also surpassed the 5,000-mark in the number of tests administered for the virus. As of Tuesday, public and private laboratories have conducted a total of 5,222 tests — 225 from public labs and 4,997 from private labs.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Red Lobster: Cater to Mom and pre-order your Mother’s Day celebration
Next article
Three McAllen High Medical Assistant Students Earn Accolades

More Articles

STHS Edinburg Solidifies Leadership in Advanced Care with Triple Surgical Reaccreditation

There’s no doubt that advancements in surgical technology are changing lives, shifting care away from traditional open procedures toward less invasive, more precise techniques that promote faster healing and improved outcomes.

STHS Heart Earns Level 3 Geriatric Emergency Department Accreditation

Health challenges can affect individuals at any stage of life, but the likelihood of complications rises significantly with age.

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -